EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Headline of release should read: Dutton Associates Announces Investment
Opinion: Applied NeuroSolutions Strong Speculative Buy Rating...
VERNON HILLS, Ill.--(BUSINESS WIRE)--Biopharmaceutical company Applied NeuroSolutions, Inc. (OTCBB:APNS)(www.appliedneurosolutions.com)
today announced Dutton Associates, an independent...
VERNON HILLS, Ill.--(BUSINESS WIRE)--Biopharmaceutical company Applied NeuroSolutions, Inc. (OTCBB:APNS)(www.appliedneurosolutions.com)
today announced an agreement with Eli Lilly and...
VERNON HILLS, Ill.--(BUSINESS WIRE)--Sept. 7, 2006--Applied NeuroSolutions, Inc. (OTCBB:APNS)(www.appliedneurosolutions.com), a biopharmaceutical company developing novel therapeutic targets for...
VERNON HILLS, Ill.--(BUSINESS WIRE)--Aug. 29, 2006-- Former Searle, Baxter and American Pharmaceutical Partners Senior Healthcare Executive Hired to Lead the Company Applied...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Aug. 17, 2006--Dutton Associates updates its coverage of Applied NeuroSolutions, Inc. (OTCBB:APNS) maintaining a Speculative Buy rating. The 12-page report...
VERNON HILLS, Ill.--(BUSINESS WIRE)--July 19, 2006--Applied NeuroSolutions, Inc. (OTCBB:APNS) (www.appliedneurosolutions.com), a biopharmaceutical company developing novel therapeutic targets for...
VERNON HILLS, Ill.--(BUSINESS WIRE)--June 27, 2006--Applied NeuroSolutions, Inc. (OTC BB:APNS) (www.appliedneurosolutions.com), a biopharmaceutical company focused on novel therapeutic targets for...
VERNON HILLS, Ill.--(BUSINESS WIRE)--Jan. 4, 2006--An increase in a specific, abnormal brain protein appears to herald the onset of Alzheimer's disease (AD), according to a study soon to be...
VERNON HILLS, Ill.--(BUSINESS WIRE)--Dec. 12, 2005--Applied NeuroSolutions, Inc. (OTCBB:APNS), a Company focused on the development of an integrated product portfolio for the diagnosis and...
VERNON HILLS, Ill.--(BUSINESS WIRE)--Dec. 6, 2005--Applied NeuroSolutions, Inc. (OTCBB:APNS), a Company focused on the development of an integrated product portfolio for the diagnosis and treatment...
#16: APNS News Applied NeuroSolutions Appoints Inamed Executive Robert S. Vaters to its Board of Directors; Senior Business Executive Provides Operational, Financial and Business Development Experience
VERNON HILLS, Ill.--(BUSINESS WIRE)--Oct. 20, 2005--Applied NeuroSolutions, Inc. (OTCBB:APNS) (www.appliedneurosolutions.com) today announced the appointment of Robert S. Vaters to its Board of...
VERNON HILLS, Ill.--(BUSINESS WIRE)--Oct. 18, 2005--Applied NeuroSolutions (OTCBB:APNS) (www.appliedneurosolutions.com) today announced that its Alzheimer's disease diagnostic test is scheduled to...
VERNON HILLS, Ill.--(BUSINESS WIRE)--Oct. 12, 2005--A test developed by Applied NeuroSolutions (OTC BB:APNS)(www.appliedneurosolutions.com) to detect Alzheimer's disease (AD) improves upon current...
VERNON HILLS, Ill.--(BUSINESS WIRE)--Sept. 22, 2005--Applied NeuroSolutions, Inc. (OTC BB:APNS) (www.appliedneurosolutions.com), a biotechnology company dedicated to developing products to diagnose...